开云app官网登录入口网页版-官方正版

#HCA#

24篇内容 | 1375人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2218948, encodeId=45e4221894855, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=European Radiology：新型肝细胞腺瘤亚群（shHCA）磁共振成像特征及其与组织学的相关性, objectType=article, longId=838064, objectId=76d0838064f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719539714497_5579292.jpg, objectUrl=/article/show_article.do?id=76d0838064f3, replyNumber=0, likeNumber=35, createdTime=2024-08-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=76d0838064f3, moduleTitle=European Radiology：新型肝细胞腺瘤亚群（shHCA）磁共振成像特征及其与组织学的相关性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=76d0838064f3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1685481, encodeId=7767168548148, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=BMC Pulm Med：新冠肺炎急性呼吸窘迫综合征的低氧血症和肺力学在NorthCARDS数据集中的轨迹, objectType=article, longId=299601, objectId=d564299601ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d564299601ef, replyNumber=0, likeNumber=0, createdTime=2022-05-19, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d564299601ef, moduleTitle=BMC Pulm Med：新冠肺炎急性呼吸窘迫综合征的低氧血症和肺力学在NorthCARDS数据集中的轨迹, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d564299601ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685479, encodeId=3bf016854e904, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=武田和Frazier Healthcare Partners宣布合作成立HilleVax, Inc.以开发临床阶段诺如病毒候选疫苗, objectType=article, longId=215179, objectId=45d52151e9f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45d52151e9f8, replyNumber=0, likeNumber=86, createdTime=2021-10-08, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45d52151e9f8, moduleTitle=武田和Frazier Healthcare Partners宣布合作成立HilleVax, Inc.以开发临床阶段诺如病毒候选疫苗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=45d52151e9f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685480, encodeId=6ac01685480cd, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=ViiV Healthcare宣布美国FDA已核准用于预防HIV的首个长效针剂Apretude（卡博特韦缓释注射混悬液）, objectType=article, longId=292640, objectId=6d43292640c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d43292640c9, replyNumber=0, likeNumber=71, createdTime=2022-03-25, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d43292640c9, moduleTitle=ViiV Healthcare宣布美国FDA已核准用于预防HIV的首个长效针剂Apretude（卡博特韦缓释注射混悬液）, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6d43292640c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685482, encodeId=2e79168548267, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=J Invest Dermatol：口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究, objectType=article, longId=300170, objectId=b00e3001e032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b00e3001e032, replyNumber=0, likeNumber=66, createdTime=2022-05-16, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b00e3001e032, moduleTitle=J Invest Dermatol：口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b00e3001e032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685478, encodeId=e51216854e839, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=武田在J.P. Morgan Healthcare第39届年会上介绍产品线更新和分享2030财年营收增幅达50%的目标, objectType=article, longId=205739, objectId=4d54205e3900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d54205e3900, replyNumber=0, likeNumber=111, createdTime=2021-08-12, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d54205e3900, moduleTitle=武田在J.P. Morgan Healthcare第39届年会上介绍产品线更新和分享2030财年营收增幅达50%的目标, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4d54205e3900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685477, encodeId=73c516854e7b4, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=HCare峰会：中国冠心病介入手术量全球领先，来看看北大霍勇教授怎么说, objectType=article, longId=199284, objectId=c047199284cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c047199284cc, replyNumber=0, likeNumber=68, createdTime=2021-01-21, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c047199284cc, moduleTitle=HCare峰会：中国冠心病介入手术量全球领先，来看看北大霍勇教授怎么说, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c047199284cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685475, encodeId=fd4616854e554, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=“高瓴HCare2020全球健康产业峰会”参会全攻略, objectType=article, longId=198720, objectId=796a198e20ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=796a198e20ba, replyNumber=0, likeNumber=73, createdTime=2021-01-27, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=796a198e20ba, moduleTitle=“高瓴HCare2020全球健康产业峰会”参会全攻略, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=796a198e20ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685474, encodeId=76ff16854e420, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=生物医药行业大事件！高瓴HCare全球健康产业峰会 & Mayo Clinic 中国医疗峰会重磅来袭, objectType=article, longId=197165, objectId=a37f19e16565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a37f19e16565, replyNumber=0, likeNumber=69, createdTime=2021-04-03, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a37f19e16565, moduleTitle=生物医药行业大事件！高瓴HCare全球健康产业峰会 & Mayo Clinic 中国医疗峰会重磅来袭, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a37f19e16565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685476, encodeId=ca3216854e6e9, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=高瓴易诺青：HCare将汇聚平台力量，关注“健康”梦想, objectType=article, longId=199130, objectId=2f9719913030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f9719913030, replyNumber=0, likeNumber=70, createdTime=2021-03-01, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f9719913030, moduleTitle=高瓴易诺青：HCare将汇聚平台力量，关注“健康”梦想, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2f9719913030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685473, encodeId=c7a516854e30a, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=ViiV Healthcare在美国提交了艾滋病毒新药fostemsavir的申请, objectType=article, longId=184388, objectId=272018438800, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=272018438800, replyNumber=0, likeNumber=66, createdTime=2019-12-14, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=272018438800, moduleTitle=ViiV Healthcare在美国提交了艾滋病毒新药fostemsavir的申请, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=272018438800)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685472, encodeId=82a116854e2d8, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=Celltrion Healthcare的皮下制剂CT-P13（英夫利昔单抗生物仿制药）治疗克罗恩病1期临床研究成功, objectType=article, longId=162030, objectId=356d1620300f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=356d1620300f, replyNumber=0, likeNumber=84, createdTime=2020-02-08, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=356d1620300f, moduleTitle=Celltrion Healthcare的皮下制剂CT-P13（英夫利昔单抗生物仿制药）治疗克罗恩病1期临床研究成功, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=356d1620300f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685471, encodeId=1d2416854e166, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=ViiV Healthcare和荷兰Radboud大学合作寻找HIV药物新靶标, objectType=article, longId=161427, objectId=a9cf16142ee7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9cf16142ee7, replyNumber=0, likeNumber=73, createdTime=2019-09-15, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9cf16142ee7, moduleTitle=ViiV Healthcare和荷兰Radboud大学合作寻找HIV药物新靶标, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a9cf16142ee7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685470, encodeId=082316854e09f, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=治疗艾滋病，ViiV Healthcare公司的长效注射药物2期临床数据振奋人心, objectType=article, longId=152466, objectId=84471524662d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84471524662d, replyNumber=0, likeNumber=64, createdTime=2018-12-02, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84471524662d, moduleTitle=治疗艾滋病，ViiV Healthcare公司的长效注射药物2期临床数据振奋人心, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=84471524662d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685469, encodeId=e0ae168546916, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=跨国聚焦新世代医疗科技！Taiwan Healthcare+ Expo 亚洲医疗科技合作场域** 在台湾, objectType=article, longId=150812, objectId=c61515081204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61515081204, replyNumber=0, likeNumber=66, createdTime=2018-11-25, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61515081204, moduleTitle=跨国聚焦新世代医疗科技！Taiwan Healthcare+ Expo 亚洲医疗科技合作场域** 在台湾, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c61515081204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685466, encodeId=18ca168546606, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=Journal of Healthcare L：领导力促进临床实践变革循证实践实施领导力渥太华模型, objectType=article, longId=103877, objectId=73661038e78f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73661038e78f, replyNumber=0, likeNumber=56, createdTime=2018-04-25, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73661038e78f, moduleTitle=Journal of Healthcare L：领导力促进临床实践变革循证实践实施领导力渥太华模型, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=73661038e78f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685464, encodeId=6cac1685464f1, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=重磅！ViiV&nbspHealthcare&nbspHIV新型药物组合3期临床试验获得成功, objectType=article, longId=90598, objectId=dd06905989e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd06905989e, replyNumber=0, likeNumber=58, createdTime=2017-09-02, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd06905989e, moduleTitle=重磅！ViiV&nbspHealthcare&nbspHIV新型药物组合3期临床试验获得成功, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=dd06905989e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685468, encodeId=5d9c168546826, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=康民国际医院获得Global Healthcare Accreditation认证, objectType=article, longId=120308, objectId=2a5712030801, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a5712030801, replyNumber=0, likeNumber=63, createdTime=2018-10-07, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a5712030801, moduleTitle=康民国际医院获得Global Healthcare Accreditation认证, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2a5712030801)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685465, encodeId=1c851685465a4, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=威科集团升至Healthcare Informatics百强医疗IT公司第23位, objectType=article, longId=103371, objectId=27b91033e122, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27b91033e122, replyNumber=0, likeNumber=71, createdTime=2017-10-07, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27b91033e122, moduleTitle=威科集团升至Healthcare Informatics百强医疗IT公司第23位, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=27b91033e122)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685467, encodeId=8808168546e59, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, objectTitle=Toxicol Sci：肠道微生物竟然可以降低致癌杂环胺HCA毒性！, objectType=article, longId=112701, objectId=fffb112e01db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fffb112e01db, replyNumber=0, likeNumber=65, createdTime=2018-04-15, rootId=0, userName=tsing_hit, userId=ad4a28195983, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fffb112e01db, moduleTitle=Toxicol Sci：肠道微生物竟然可以降低致癌杂环胺HCA毒性！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=fffb112e01db)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

HCA

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#HCA#

European Radiology：新型肝细胞腺瘤亚群（shHCA）磁共振成像特征及其与组织学的相关性

2024-08-07发表于上海

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

BMC Pulm Med：新冠肺炎急性呼吸窘迫综合征的低氧血症和肺力学在NorthCARDS数据集中的轨迹

2022-05-19

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

武田和Frazier Healthcare Partners宣布合作成立HilleVax, Inc.以开发临床阶段诺如病毒候选疫苗

2021-10-08

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

ViiV Healthcare宣布美国FDA已核准用于预防HIV的首个长效针剂Apretude（卡博特韦缓释注射混悬液）

2022-03-25

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

J Invest Dermatol：口服富马酸二甲酯在咪喹莫特小鼠模型中靶向HCA2表达的研究

2022-05-16

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

武田在J.P. Morgan Healthcare第39届年会上介绍产品线更新和分享2030财年营收增幅达50%的目标

2021-08-12

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

HCare峰会：中国冠心病介入手术量全球领先，来看看北大霍勇教授怎么说

2021-01-21

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

“高瓴HCare2020全球健康产业峰会”参会全攻略

2021-01-27

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

生物医药行业大事件！高瓴HCare全球健康产业峰会 & Mayo Clinic 中国医疗峰会重磅来袭

2021-04-03

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

高瓴易诺青：HCare将汇聚平台力量，关注“健康”梦想

2021-03-01

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

ViiV Healthcare在美国提交了艾滋病毒新药fostemsavir的申请

2019-12-14

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

Celltrion Healthcare的皮下制剂CT-P13（英夫利昔单抗生物仿制药）治疗克罗恩病1期临床研究成功

2020-02-08

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

ViiV Healthcare和荷兰Radboud大学合作寻找HIV药物新靶标

2019-09-15

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

治疗艾滋病，ViiV Healthcare公司的长效注射药物2期临床数据振奋人心

2018-12-02

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

跨国聚焦新世代医疗科技！Taiwan Healthcare+ Expo 亚洲医疗科技合作场域** 在台湾

2018-11-25

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

Journal of Healthcare L：领导力促进临床实践变革循证实践实施领导力渥太华模型

2018-04-25

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

重磅！ViiV&nbspHealthcare&nbspHIV新型药物组合3期临床试验获得成功

2017-09-02

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

康民国际医院获得Global Healthcare Accreditation认证

2018-10-07

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

威科集团升至Healthcare Informatics百强医疗IT公司第23位

2017-10-07

tsing_hit (审核中...)

前往app查看评论内容

#HCA#

Toxicol Sci：肠道微生物竟然可以降低致癌杂环胺HCA毒性！

2018-04-15

科室
- - 订阅+
  - 更多科室
工具
服务